NCT03846128 2026-04-14
BIOSUNTOX
University Hospital, Rouen
Terminated
Clinical Trials
17 trialsNCT02087852 2026-04-09
Kidney Cancer DNA Registry
Memorial Sloan Kettering Cancer Center
Recruiting
NCT06020651 2026-04-08
VICKI
Institut Mutualiste Montsouris
Phase NA Completed
NCT02822404 2026-04-01
CysPed
University Hospital, Toulouse
Phase NA Completed
NCT07054346 2026-04-01
LUTACT
University of California, San Francisco
Phase 1 Recruiting
NCT04167969 2026-03-27
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06435546 2026-03-27
AdOTAC
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT03185039 2026-03-19
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Institut Paoli-Calmettes
Phase NA Active not recruiting
NCT05435495 2026-03-18
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Recruiting
NCT06349642 2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
NCT07463508 2026-03-11
TG-BIL
University Hospital, Clermont-Ferrand
Phase NA Recruiting
NCT06960798 2026-03-02
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
University of Oklahoma
Recruiting
NCT04662996 2026-02-12
MiR_CPMRC
University Hospital, Tours
Phase NA Completed
NCT07406646 2026-02-12
EXO-RENAL1
Institute of Oncology Ljubljana
Phase NA Completed
NCT05890781 2026-02-09
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT06492122 2026-01-29
ProTACT
Full-Life Technologies GmbH
Phase 1 Recruiting
NCT06674811 2026-01-26
BRICCS
Mayo Clinic
Recruiting